| |
 |
|
|
|
|
|
Poster: 158
Visits: 149
Title: Cell of origin is not associated with survival after DLBCL relapse
Authors: Umar Farooq , Matthew J. Maurer, Carrie A. Thompson, Tasha L. Lin, Andrew L. Feldman, William R. Macon, Sergei Syrbu, James R. Cerhan, Thomas E. Witzig, Thomas M. Habermann, Stephen M. Ansell, Brian K. Link, Grzegorz S. Nowakowski
Centre: University of Iowa Hospitals and Clinics
|
|
You must be registered to reply or comment.
|
|
CELL OF ORIGIN IS NOT ASSOCIATED WITH SURVIVAL AFTER DLBCL RELAPSE
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 154
Visits: 188
Title: NR4A3 suppresses lymphomagenesis by induction of apoptosis and serves as a drug target for lymphoma therapy
Authors: Alexander Deutsch ,
Centre: Clinical Devision of Hematology
|
|
|
|
